SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 76.07+0.9%Nov 12 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1176)7/1/2005 11:48:44 AM
From: Jibacoa  Read Replies (2) of 3722
 
XOMA is trying to find support at the 1.68 level, although its major support at present seems to be at 1.54 <g>

In spite of some insiders sales, the stock remains on the nearterm uptrend that started on May 4 from the 1.04 level.

The results for the 1st Q were better with revenues up from 0.17M to 3M and the loss down to $0.12/shr vs. $0.24/shr in 2004. For 2005 the EL is around $0.43/shr vs. $0.93/shr in 2004.

The stock is up around 3% on volume of 258Ks and is one stock to keep on a watch list for those fond of "bottom fishing".<g>

On Monday Wells Fargo initiated coverage of XOMA with a "buy" rating.<g>

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext